Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Guselkumab loss of exclusitivy?Is clarinex off patent?Allergan's patent for latisse expired?Dabrafenib and trametinib price?Albendazole side effects in humans?
See the DrugPatentWatch profile for ruxolitinib
The provided information does not include the date Apotex filed its ruxolitinib (Jakafi/ruxolitinib) application or any timeline showing when it was approved or otherwise resolved. Without those filing and disposition dates, the length of the “pending” period can’t be determined from the available material. If you share the specific application (e.g., jurisdiction/regulatory body such as US FDA AND the filing and approval dates, or a link/source for the application record), I can calculate how long it was pending.
Other Questions About Ruxolitinib :